MGLN Magellan Health Inc

Price (delayed)

$94.25

Market cap

$2.46B

P/E Ratio

6.09

Dividend/share

N/A

EPS

$15.48

Enterprise value

$2.54B

Highlights
The stock's price to earnings (P/E) is 85% less than its 5-year quarterly average of 41.5 and 36% less than its last 4 quarters average of 9.5
Magellan Health's quick ratio has soared by 76% YoY and by 2.9% from the previous quarter
Magellan Health's gross profit has increased by 20% QoQ but it has decreased by 19% YoY
Magellan Health's gross margin has increased by 19% from the previous quarter but it has decreased by 18% YoY

Key stats

What are the main financial stats of MGLN
Market
Shares outstanding
26.13M
Market cap
$2.46B
Enterprise value
$2.54B
Valuations
Price to earnings (P/E)
6.09
Price to book (P/B)
1.28
Price to sales (P/S)
0.53
EV/EBIT
6.67
EV/EBITDA
5.16
EV/Sales
0.55
Earnings
Revenue
$4.62B
EBIT
$380.86M
EBITDA
$492.34M
Free cash flow
$261.86M
Per share
EPS
$15.48
Free cash flow per share
$10.08
Book value per share
$73.54
Revenue per share
$177.8
TBVPS
$88.23
Balance sheet
Total assets
$3.24B
Total liabilities
$1.29B
Debt
$533.23M
Equity
$1.91B
Working capital
$1.36B
Liquidity
Debt to equity
0.28
Current ratio
3.06
Quick ratio
2.83
Net debt/EBITDA
0.16
Margins
EBITDA margin
10.7%
Gross margin
3.1%
Net margin
8.5%
Operating margin
0.4%
Efficiency
Return on assets
11.8%
Return on equity
22.7%
Return on invested capital
22.6%
Return on capital employed
14.8%
Return on sales
8.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MGLN stock price

How has the Magellan Health stock price performed over time
Intraday
-0.06%
1 week
-0.01%
1 month
-0.07%
1 year
39.55%
YTD
13.77%
QTD
1.08%

Financial performance

How have Magellan Health's revenue and profit performed over time
Revenue
$4.62B
Gross profit
$142.07M
Operating income
$19.39M
Net income
$391.91M
Gross margin
3.1%
Net margin
8.5%
Magellan Health's operating margin has plunged by 73% YoY
Magellan Health's operating income has shrunk by 71% YoY
Magellan Health's gross profit has increased by 20% QoQ but it has decreased by 19% YoY
Magellan Health's gross margin has increased by 19% from the previous quarter but it has decreased by 18% YoY

Growth

What is Magellan Health's growth rate over time

Valuation

What is Magellan Health stock price valuation
P/E
6.09
P/B
1.28
P/S
0.53
EV/EBIT
6.67
EV/EBITDA
5.16
EV/Sales
0.55
The stock's price to earnings (P/E) is 85% less than its 5-year quarterly average of 41.5 and 36% less than its last 4 quarters average of 9.5
MGLN's EPS is up by 2.2% since the previous quarter
MGLN's equity is up by 33% year-on-year and by 2.1% since the previous quarter
The P/B is 9% less than the 5-year quarterly average of 1.4 but 7% more than the last 4 quarters average of 1.2
MGLN's price to sales (P/S) is 33% higher than its 5-year quarterly average of 0.4 and 6% higher than its last 4 quarters average of 0.5

Efficiency

How efficient is Magellan Health business performance
MGLN's ROS has soared by 193% year-on-year
MGLN's return on invested capital has surged by 163% year-on-year but it is down by 2.2% since the previous quarter
The company's return on equity fell by 4.6% QoQ
MGLN's ROA is up by 2.6% since the previous quarter

Dividends

What is MGLN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MGLN.

Financial health

How did Magellan Health financials performed over time
The total assets is 150% more than the total liabilities
Magellan Health's quick ratio has soared by 76% YoY and by 2.9% from the previous quarter
Magellan Health's current ratio has soared by 75% YoY and by 4.8% from the previous quarter
Magellan Health's debt is 72% lower than its equity
MGLN's debt to equity is down by 45% YoY and by 18% QoQ
MGLN's equity is up by 33% year-on-year and by 2.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.